Diagnosis and susceptibility testing of methicillin-resistant staphylococcus aureus in Latin America

Brazilian Journal of Infectious Diseases

Volumn 14, Issue SUPPL. 2, 2010, Pages

  Zurita, Jeannete ^a   Mejía, Carlos ^b   Guzmán Blanco, Manuel ^c  

^a HOSPITAL VOZANDES   (Ecuador)

^b Roosevelt Hospital Guatemala   (Guatemala)

^c Centro Medico Docente La Trinidad   (Venezuela)

Author keywords

Diagnosis; Latin America; MRSA; Susceptibility testing

Indexed keywords

CEFOXITIN; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; LINEZOLID; METICILLIN; OXACILLIN; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; CLINICAL PRACTICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE PREDISPOSITION; HEALTH CARE ACCESS; HEALTH CARE PERSONNEL; HUMAN; MEDICAL EDUCATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; PRACTICE GUIDELINE; QUALITY CONTROL; SOUTH AND CENTRAL AMERICA;

EID: 78650841774     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1590/s1413-86702010000800005     Document Type: Article

References (41)

1. Guzmán-Blanco M, Mejía C, Isturiz R et al. Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in Latin America. Int J Antimicrob Agents. 2009; 34(4):304-8.
2. Woodford N, Livermore DM. Infections caused by Gram-positive bacteria: a review of the global challenge. J Infect. 2009; 59(1):S4-16.
3. Rodriguez-Noriega E, Seas C, Guzmán-Blanco M et al. Evolution of methicillin-resistant Staphylococcus aureus clones in Latin America. Int J Infect Dis. 2010; 14:e560-e6.
4. CLSI. Performance Standards for Antimicrobial Susceptibility Testing; Nineteenth Informational Supplement (M100-S19). 2009. Clinical and Laboratory Standards Institute. Wayne, PA. (http://www.clsi.org/source/orders/free/m100-s19.pdf) Accessed 23 November 2009.
5. CLSI. Surveillance for Methicillin-Resistant Staphylococcus aureus: Principles, Practices, and Challenges; A Report. CLSI document X07-R. 2010. Clinical and Laboratory Standards Institute, Wayne, PA. (http://www.clsi.org/source/orders/free/x07-r.pdf) Accessed 7 May 2010.
6. EARSS. New and updated protocols for antimicrobial susceptibility testing of pathogens under EARSS surveillance 2005. (http://www.rivm.nl/earss/Images/Earss%20manual2005_tcm61-21261.pdf) Accessed 18 October 2009.
7. Cano ME, Dominguez MA, Baquedano CE et al. Cultivos de vigilancia epidemiologica de bacterias resistentes a los antimicrobianos de interes nosocomial. (http://www.seimc.org/documentos/protocolos/microbiologia/) Accessed 10 November 2009.
8. Andrews JM. BSAC standardized disc susceptibility testing method (version 7). J Antimicrob Chemother. 2008; 62(2):256-78.
9. Brown DF, Edwards DI, Hawkey PM et al. Guidelines for the laboratory diagnosis and susceptibility testing of methicillinresistant Staphylococcus aureus (MRSA). J Antimicrob Chemother. 2005; 56(6):1000-18.
10. EARSS. Protocols and Guidelines: Technical guide for the detection of Staphylococcus aureus with reduced susceptibility to glycopeptides (VISA/VRSA). (www.earss.rivm.nl) Accessed 6 May 2010.
11. van Griethuysen A, Bes M, Etienne J et al. International multicenter evaluation of latex agglutinates tests for identification of methicillin-resistance Staphylococcus aureus (MRSA). J Clin Microbiol. 2001; 39(1):86-9.
12. Iorio NL, Ferreira RB, Schuenck RP et al. Simplified and reliable scheme for species-level identification of Staphylococcus clinical isolates. J Clin Microbiol. 2007; 45(8):2564-9.
13. Cauwelier B, Gordts B, Descheemaecker P, Van Landuyt H. Evaluation of a disk diffusion method with cefoxitin (30 microg) for detection of methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis. 2004; 23(5):389-92.
14. Skov R, Smyth R, Clausen M et al. Evaluation of a cefoxitin 30 microg disc on Iso-Sensitest agar for detection of methicillin- resistant Staphylococcus aureus. J Antimicrob Chemother. 2003; 52(2):204-7.
15. Huang MB, Gay TE, Baker CN et al. Two percent sodium chloride is required for susceptibility testing of staphylococci with oxacillin when using agar-based dilution methods. J Clin Microbiol. 1993; 31(10):2683-8.
16. Novak SM, Hindler J, Bruckner DA. Reliability of two novel methods, Alamar and E test, for detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol. 1993; 31(11):3056-7.
17. Petersson AC, Miorner H, Kamme C. Identification of mecArelated oxacillin resistance in staphylococci by the E test and the broth microdilution method. J Antimicrob Chemother. 1996; 37(3):445-56.
18. Weller TM, Crook DW, Crow MR et al. Methicillin susceptibility testing of staphylococci by Etest and comparison with agar dilution and mecA detection. J Antimicrob Chemother. 1997; 39(2):251-3.
19. Perry JD, Rennison C, Butterworth LA et al. Evaluation of S. aureus ID, a new chromogenic agar medium for detection of Staphylococcus aureus. J Clin Microbiol. 2003; 41(12):5695-8.
20. Hedin G, Fang H. Evaluation of two new chromogenic media, CHROMagar MRSA and S. aureus ID, for identifying Staphylococcus aureus and screening methicillin-resistant S. aureus. J Clin Microbiol. 2005; 43(8):4242-4.
21. Brown DF, Yates VS. Methicillin susceptibility testing of Staphylococcus aureus on media containing five percent sodium chloride. Eur J Clin Microbiol. 1986; 5(6):726-8.
22. Milne LM, Curtis GD, Crow M et al. Comparison of culture media for detecting methicillin resistance in Staphylococcus aureus and coagulase negative staphylococci. J Clin Pathol. 1987; 40(10):1178-81.
23. Annear DI. The effect of temperature on resistance of Staphylococcus aureus to methicillin and some other antibioics. Med J Aust. 1968; 1(11):444-6.
24. Merlino J, Watson J, Rose B et al. Detection and expression of methicillin/oxacillin resistance in multidrug-resistant and nonmultidrug- resistant Staphylococcus aureus in Central Sydney, Australia. J Antimicrob Chemother. 2002; 49(5):793-801.
25. Mouton RP, Mulders SL, de Knijff J, Hermans J. Comparison of test systems for recognition of methicillin resistance in Staphylococcus aureus. Eur J Clin Microbiol Infect Dis. 1989; 8(11):968-73.
26. Felten A, Grandry B, Lagrange PH, Casin I. Evaluation of three techniques for detection of low-level methicillin-resistant Staphylococcus aureus (MRSA): a disk diffusion method with cefoxitin and moxalactam, the Vitek 2 system, and the MRSA-screen latex agglutination test. J Clin Microbiol. 2002; 40(8):2766-71.
27. Mougeot C, Guillaumat-Tailliet J, Libert JM. Staphylococcus aureus: new detection of intrinsic resistance using the diffusion method. Pathol Biol (Paris). 2001; 49(3):199-204.
28. Hiramatsu K, Aritaka N, Hanaki H et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet. 1997; 350(9092):1670-3.
29. Oliveira GA, Dell'Aquila AM, Masiero RL et al. Isolation in Brazil of nosocomial Staphylococcus aureus with reduced susceptibility to vancomycin. Infect Control Hosp Epidemiol. 2001; 22(7):443-8.
30. Picao R, Sader H, Jones R et al. Analysis of resistance and vancomycin 'reverse creep' in Latin America Staphylococcus aureus: ten-year report of the SENTRY Antimicrobial Surveillance Program (1997-2006). Clin Microbiol Infect. 2008; 14:S173.
31. CDC. Vancomycin-resistant Staphylococcus aureus. Morb Mortal Wkly Rep. 2004; 53:322-4.
32. Tenover FC, Weigel LM, Appelbaum PC et al. Vancomycinresistant Staphylococcus aureus isolate from a patient in Pennsylvania. Antimicrob Agents Chemother. 2004; 48(1):275-80.
33. Sakoulas G, Moise-Broder PA, Schentag J et al. Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol. 2004; 42(6):2398-402.
34. Yusof A, Engelhardt A, Karlsson A et al. Evaluation of a new Etest vancomycin-teicoplanin strip for detection of glycopeptide- intermediate Staphylococcus aureus (GISA), in particular, heterogeneous GISA. J Clin Microbiol. 2008; 46(9):3042-7.
35. Wootton M, MacGowan AP, Walsh TR, Howe RA. A multicenter study evaluating the current strategies for isolating Staphylococcus aureus strains with reduced susceptibility to glycopeptides. J Clin Microbiol. 2007; 45(2):329-32.
36. Hiramatsu K, Hanaki H, Ino T et al. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother. 1997; 40(1):135-6.
37. Marchese A, Balistreri G, Tonoli E et al. Heterogeneous vancomycin resistance in methicillin-resistant Staphylococcus aureus strains isolated in a large Italian hospital. J Clin Microbiol. 2000; 38(2):866-9.
38. Ariza J, Pujol M, Cabo J et al. Vancomycin in surgical infections due to methicillin-resistant Staphylococcus aureus with heterogeneous resistance to vancomycin. Lancet. 1999; 353(9164):1587-8.
39. Reyes J, Rincon S, Diaz L et al. Dissemination of methicillinresistant Staphylococcus aureus USA300 sequence type 8 lineage in Latin America. Clin Infect Dis. 2009; 49(12):1861-7.
40. Howe RA, Wootton M, Walsh TR et al. Expression and detection of hetero-vancomycin resistance in Staphylococcus aureus. J Antimicrob Chemother. 1999; 44(5):675-8.
41. Boyle-Vavra S, Berke SK, Lee JC, Daum RS. Reversion of the glycopeptide resistance phenotype in Staphylococcus aureus clinical isolates. Antimicrob Agents Chemother. 2000; 44(2):272-7.